Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF–identified Rifampicin-resistant Tuberculosis in Post-conflict Eastern Democratic Republic of the Congo, 2012–2017: A Retrospective Province-Wide Cohort Study

BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) jeopardizes global TB control. The prevalence and predictors of Rifampicin-resistant (RR) TB, a proxy for MDR-TB, and the treatment outcomes with standard and shortened regimens have not been assessed in post-conflict regions, such as the South K...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulabula, André N H, Nelson, Jenna A, Musafiri, Eric M, Machekano, Rhoderick, Sam-Agudu, Nadia A, Diacon, Andreas H, Shah, Maunank, Creswell, Jacob, Theron, Grant, Warren, Robin M, Jacobson, Karen R, Chirambiza, Jean-Paul, Kalumuna, Dieudonné, Bisimwa, Bertin C, Katoto, Patrick D M C, Kaswa, Michel K, Birembano, Freddy M, Kitete, Liliane, Grobusch, Martin P, Kashongwe, Zacharie M, Nachega, Jean B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763636/
https://www.ncbi.nlm.nih.gov/pubmed/30759187
http://dx.doi.org/10.1093/cid/ciy1105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763636/
https://www.ncbi.nlm.nih.gov/pubmed/30759187
http://dx.doi.org/10.1093/cid/ciy1105

Ejemplares similares